OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of m6A RNA methylation in cardiovascular disease (Review)
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 215
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 215
Showing 1-25 of 215 citing articles:
The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1244
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1244
mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification
Rajesh Kumari, Prabhat Ranjan, Zainab Suleiman, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 7, pp. 1680-1692
Open Access | Times Cited: 130
Rajesh Kumari, Prabhat Ranjan, Zainab Suleiman, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 7, pp. 1680-1692
Open Access | Times Cited: 130
METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA
Liping Meng, Hui Lin, Xingxiao Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107
Liping Meng, Hui Lin, Xingxiao Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107
m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling
Xin Liu, Hongjuan He, Fengwei Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 107
Xin Liu, Hongjuan He, Fengwei Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 107
Vascular mechanotransduction
Michael J. Davis, Scott Earley, Yi‐Shuan Li, et al.
Physiological Reviews (2023) Vol. 103, Iss. 2, pp. 1247-1421
Closed Access | Times Cited: 92
Michael J. Davis, Scott Earley, Yi‐Shuan Li, et al.
Physiological Reviews (2023) Vol. 103, Iss. 2, pp. 1247-1421
Closed Access | Times Cited: 92
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70
PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification
Xiaolan Guo, Yuyin Lin, Yingnan Lin, et al.
Environmental Pollution (2022) Vol. 303, pp. 119115-119115
Closed Access | Times Cited: 68
Xiaolan Guo, Yuyin Lin, Yingnan Lin, et al.
Environmental Pollution (2022) Vol. 303, pp. 119115-119115
Closed Access | Times Cited: 68
m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma
Xin-yu Li, Zhijie Zhao, Jing-Bing Wang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 65
Xin-yu Li, Zhijie Zhao, Jing-Bing Wang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 65
Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling
Bu-Hui Liu, Yue Tu, Guang-Xia Ni, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 77
Bu-Hui Liu, Yue Tu, Guang-Xia Ni, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 77
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 67-82
Open Access | Times Cited: 67
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 67-82
Open Access | Times Cited: 67
FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt
Weiliang Shen, Hongqi Li, Hao Su, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 5, pp. 2171-2179
Closed Access | Times Cited: 63
Weiliang Shen, Hongqi Li, Hao Su, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 5, pp. 2171-2179
Closed Access | Times Cited: 63
A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma
Jiaheng Xie, Haobo Li, Chen Liang, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6517-6527
Open Access | Times Cited: 53
Jiaheng Xie, Haobo Li, Chen Liang, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6517-6527
Open Access | Times Cited: 53
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke
Hongtao Chang, Yang Jun, Qianwen Wang, et al.
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 3, pp. 295-303
Closed Access | Times Cited: 43
Hongtao Chang, Yang Jun, Qianwen Wang, et al.
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 3, pp. 295-303
Closed Access | Times Cited: 43
iLoc-miRNA: extracellular/intracellular miRNA prediction using deep BiLSTM with attention mechanism
Zhao‐Yue Zhang, Lin Ning, Xiucai Ye, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 39
Zhao‐Yue Zhang, Lin Ning, Xiucai Ye, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 39
Mechanism of METTL3-Mediated m6A Modification in Cardiomyocyte Pyroptosis and Myocardial Ischemia–Reperfusion Injury
Xiang Wang, Yi Li, Jiahan Li, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 37, Iss. 3, pp. 435-448
Closed Access | Times Cited: 36
Xiang Wang, Yi Li, Jiahan Li, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 37, Iss. 3, pp. 435-448
Closed Access | Times Cited: 36
N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
Zhiying Zhao, Qiang Ju, Jing Ji, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
Zhiying Zhao, Qiang Ju, Jing Ji, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
The role of RNA m6A methylation in lipid metabolism
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 36
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 36
Vascular calcification: Molecular mechanisms and therapeutic interventions
Wei Pan, Wei Jie, Hui Huang
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 34
Wei Pan, Wei Jie, Hui Huang
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 34
RNA-binding proteins in cardiovascular biology and disease: the beat goes on
Mirko Völkers, Thomas Preiß, Matthias W. Hentze
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 361-378
Closed Access | Times Cited: 9
Mirko Völkers, Thomas Preiß, Matthias W. Hentze
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 361-378
Closed Access | Times Cited: 9
Silencing of METTL3 prevents the proliferation, migration, epithelial-mesenchymal transition, and renal fibrosis of high glucose-induced HK2 cells by mediating WISP1 in m6A-dependent manner
Yuanzhen Chen, Ping Li, Mei Lin, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1237-1248
Open Access | Times Cited: 8
Yuanzhen Chen, Ping Li, Mei Lin, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1237-1248
Open Access | Times Cited: 8
Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner
Zengyao Tang, Xin Huang, Hanying Mei, et al.
Journal of Bioenergetics and Biomembranes (2024) Vol. 56, Iss. 2, pp. 149-157
Closed Access | Times Cited: 6
Zengyao Tang, Xin Huang, Hanying Mei, et al.
Journal of Bioenergetics and Biomembranes (2024) Vol. 56, Iss. 2, pp. 149-157
Closed Access | Times Cited: 6
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 6
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 6
RNA N4‐acetylcytidine modification and its role in health and diseases
Qiang Wang, Yixiao Yuan, Qiang Zhou, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Qiang Wang, Yixiao Yuan, Qiang Zhou, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
The Role of Epigenetics in Cardiovascular Disease: Providing Insights into Disease Mechanisms and Evaluating Therapeutic Potential for Future Treatment Strategies
Omar Elsaka
APIK Journal of Internal Medicine (2025)
Open Access
Omar Elsaka
APIK Journal of Internal Medicine (2025)
Open Access
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
